10th Annual Biosimilars Asia

China steadfastly continues to work regulations on biosimilars to help make the market easier to breakthrough, and the recent Priority Review legislation is a case in point. As the industry continues to evaluate cost, risk and incentives for Biosimilar development, new developments to promote R&D and adjustments to approval pathways are designed to help manufacturing … Continue reading “10th Annual Biosimilars Asia”

page 1 of 2

why go to a conference?

Get high-quality practical information

Meet experts and in the field

Expand your client network


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more